the staff of the Ridgewood blog
Ridgewood NJ, Pfizer has started stage one clinical trials on an oral pill designed to be an early intervention for Covid-19. The pill has demonstrated potent in-vitro antiviral activity against SARS-CoV-2. It can be used with other antivirals to create a treatment that complements vaccination. The pill is a protease inhibitor. It binds to a viral enzyme to prevent the virus from replicating in the cell. More information about the clinical trials will be shared on April 6.
